US-based biotech company Advanced Aesthetic Technologies (AAT) has introduced its agarose-based facial filler, Algeness VL, to China's fast-expanding medical aesthetics market, marking a new milestone in facial contouring and reconstruction treatments.
The product received approval from China's National Medical Products Administration, according to AAT's Chinese distributor, China Biotics, on October 28. Algeness VL is already sold in more than 40 countries and regions worldwide.
China's injectable aesthetics market has grown rapidly, surging over 2.5 times from 2018 to 2023 to reach CNY 67 billion (USD 9.4 billion) — a 21.1% compound annual growth rate, public data show. Consultancy Frost & Sullivan projects the market will more than double again to CNY 147 billion (USD 20.6 billion) by 2027.
While demand for advanced fillers is soaring, few Chinese firms are developing agarose-based products like AAT's. One notable exception is Shanghai-based Petal Biotechnology, which began constructing a production facility for similar fillers last month.
US Biotech Firm Launches New Agarose-Based Facial Filler in China
Tags
The World Bank has revised upward its forecast for China's economy, now expecting GDP growth of 4.8% in 2025 and 4.2% in 2026, compared with its April projection of 4.0%…
China, the United States' third-largest creditor, reduced its holdings of US Treasury securities in July to the lowest level since 2009, according to the latest data. The country trimmed its US…
The U.S. Department of Health and Human Services (HHS) has recently decided to terminate 22 mRNA research contracts under the Biomedical Advanced Research and Development Authority (BARDA), drawing significant attention…
Despite ongoing U.S. export restrictions on advanced computing chips, China has emerged as the global leader in artificial intelligence (AI) research, according to a new report from the Dimensions database…
The United States has approved the resumption of aircraft component exports to China, allowing American aerospace firms, including GE Aerospace, to once again supply key parts. Boeing has also resumed…
